Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Imiquimod 5% cream may not work for treating scrotal extramammary Paget disease.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Tip cryotherapy effectively treats idiopathic guttate hypomelanosis with minimal side effects.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

An 84-year-old man got a rare scalp condition from using imiquimod cream, which was cured with systemic steroids.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

A new test using NOS2 and CCL27 genes can better diagnose and treat psoriasis and eczema.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Sorafenib can cause a unique skin reaction.

Different body areas have unique skin cell communication patterns, explaining why certain skin diseases occur in specific regions.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Topical contact sensitizers can treat certain skin conditions by changing the immune response.

The model effectively mimics radiation-induced skin damage for future research.

A test for nail fungus was most accurate with PAS stain, low-dose spironolactone helped two-thirds of acne patients, metformin reduced symptoms of HIV-related fat distribution changes with some side effects, and skin examination with dermoscopy was better at detecting abnormal moles, while temporary tattoos can cause skin reactions.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Dermoscopy improves diagnosis and treatment planning for trichostasis spinulosa.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Bortezomib chemotherapy can cause temporary skin rashes.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.